Sep. 10 at 1:26 PM
$ABCL ๐จGET in NOW! Weโre going to
$12+ THIS Week!
ABCL CEO CARL on the Call today said that PHASE 2 RESULTS were so IMPRESSIVE that PATIENTS Were โCUREDโ!
โOne of the really UNPRECEDENTED and, Iโd say, very exciting parts of the data was that in 37% of patients after a 1 dose of ABCL635, they went from a baseline of around 10 events per day to ZERO! So for a subset of a significant subset of patients, like more than a third, a 1 dose was essentially curative โCUREDโat 4weeks. And on the severity side, I think that number was like 25%. And thats important because severity if you have even a minor event, which you kind of are aware of it, it doesnโt stop you, it doesnโt really interfere with your events, that gets a score on severity. So we had about 24% W/ ZERO severity score, which means there were NO EVENTS! So NOT A SINGLE INCIDENT. So from someone that was really STRUGGLING with this to essentially ITS GONE, thats SOMETHING that you RARELY, RARELY see in drug developmentโ ๐คฏ๐คฏ ๐คฏ
